BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22504208)

  • 1. Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia.
    Kawano T; Tanaka K; Chi H; Eguchi S; Yamazaki F; Kitamura S; Kumagai N; Yokoyama M
    Anesth Analg; 2012 Jul; 115(1):62-9. PubMed ID: 22504208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abscisic Acid Stimulates Glucagon-Like Peptide-1 Secretion from L-Cells and Its Oral Administration Increases Plasma Glucagon-Like Peptide-1 Levels in Rats.
    Bruzzone S; Magnone M; Mannino E; Sociali G; Sturla L; Fresia C; Booz V; Emionite L; De Flora A; Zocchi E
    PLoS One; 2015; 10(10):e0140588. PubMed ID: 26488296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
    Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
    J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
    Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
    Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats.
    Yu Y; Wang X; Liu C; Yao D; Hu M; Li J; Hu N; Liu L; Liu X
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):375-84. PubMed ID: 23200776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of propofol and isoflurane on glucose utilization and insulin secretion.
    Tanaka K; Kawano T; Tsutsumi YM; Kinoshita M; Kakuta N; Hirose K; Kimura M; Oshita S
    Life Sci; 2011 Jan; 88(1-2):96-103. PubMed ID: 21056586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
    J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
    Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
    Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice.
    Lee S; Youn YS; Lee SH; Byun Y; Lee KC
    Diabetologia; 2006 Jul; 49(7):1608-11. PubMed ID: 16586064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
    Islam MS; Rahman SA; Mirzaei Z; Islam KB
    Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of native glucagon-like peptide 1 and dipeptidyl peptidase IV-resistant analogues on insulin release from rat pancreatic islets.
    Siegel EG; Scharf G; Gallwitz B; Mentlein R; Morys-Wortmann C; Fölsch UR; Schmidt WE
    Eur J Clin Invest; 1999 Jul; 29(7):610-4. PubMed ID: 10411667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.
    Kuhre RE; Gribble FM; Hartmann B; Reimann F; Windeløv JA; Rehfeld JF; Holst JJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G622-30. PubMed ID: 24525020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats.
    Mochida T; Hira T; Hara H
    Endocrinology; 2010 Jul; 151(7):3095-104. PubMed ID: 20410194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1 (GLP-1) in healthy volunteers.
    Meier S; Hücking K; Ritzel R; Holst JJ; Schmiegel WH; Nauck MA
    Horm Metab Res; 2003 Sep; 35(9):551-6. PubMed ID: 14517773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
    Hosokawa YA; Hosokawa H; Chen C; Leahy JL
    J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.
    Lim GE; Huang GJ; Flora N; LeRoith D; Rhodes CJ; Brubaker PL
    Endocrinology; 2009 Feb; 150(2):580-91. PubMed ID: 18818290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.